# Kalaris Therapeutics Inc (KLRS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KLRS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -44.48M | $ -44.21M | $ 1.45M | $ 78.81M |
| 2024 | $ 0 | $ -68.75M | $ -13.47M | $ 0 | $ 113.31M |
| 2023 | $ 0 | $ -145.10M | $ -105.80M | $ 0 | $ -45.02M |
| 2022 | $ 0 | $ -188.47M | $ -158.69M | $ 35.39M | $ 224.52M |
| 2021 | $ 0 | $ -204.40M | $ -126.41M | $ 30.07M | $ 225.27M |
| 2020 | $ 0 | $ -88.90M | $ -77.77M | $ 8.69M | $ 353.06M |
| 2019 | $ 213.0K | $ -30.77M | $ -23.90M | $ 11.76M | $ 121.62M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.54 |
| Current Ratio | 12.23 |

## Other views

- [Metrics](https://sponda.capital/en/KLRS.md)
- [Charts](https://sponda.capital/en/KLRS/charts.md)
- [Compare](https://sponda.capital/en/KLRS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.